We Address Unmet Medical Needs to Improve Patient Outcomes and Quality of Life
EffRx Announces the Appointment of Göran Linder to of the Board of Directors
The product portfolio is led by already commercialized Binosto® for the treatment of postmenopausal osteoporosis.
Partnering with Us
Our strategy relies on partnerships for shared commercial success. We welcome you to find out more about partnering.